In the last three months of 2022, physicians signed more than 9 million prescriptions for obesity drug Saxenda and two diabetes medications, Ozempic and Mounjaro, according to a report by Trilliant Health, a data analytics company. 

Accredo Health Group, a specialty pharmacy owned by the Cigna Group, is planning to expand its business in Delaware, the Delaware Business Times reported Sept. 25.

The FDA has issued warnings to at least 28 manufacturers of over-the-counter medications and health products this year for failing to adequately test ingredients for toxins that caused hundreds of deaths overseas, according to a Sept. 26 exclusive report from…

From 2021 to 2022, the 340B drug pricing program grew 22 percent, according to a Sept. 24 Drug Channels report. 

Some CVS pharmacists in Kansas City are calling out of work Sept. 27 to bring attention to increasingly difficult working conditions, USA Today reported. 

One cancer drug shortage has ended and at least 14 oncology drugs are in short supply, according to the FDA, the American Society of Health-System Pharmacists and physicians. 

The market for drugs like Eli Lilly's Mounjaro and Novo Nordisk's Ozempic and Wegovy is projected to reach $100 billion by 2035, Fortune reported Sept. 22.

VCU Health is doubling down on its pharmacy strategy and mail-order medication services, according to Michael Roussos, president of VCU Medical Center.

For the first time in Florida, physicians administered a recently approved gene therapy for Duchenne muscular dystrophy to a pediatric patient. 

As the supply of two staple cancer drugs rebounds after months of scarcity, two medications used in pediatric cancer patients have fallen into shortage, NBC News reported Sept. 25.